zynerba

  1. Ron Strider

    Can This Beaten-Down Marijuana Stock Roar Back In 2018

    There was good news and bad news for Zynerba Pharmaceuticals in 2017. First, the good news: The cannabinoid-focused biotech stock is up more than 90% over the last three months. What's the bad news? That gain wasn't enough to offset Zynerba's previous decline. The stock is still down over 20%...
  2. Ron Strider

    5 Things You Need To Know About Marijuana Stock

    There are three different general types of marijuana stocks on the market. Some are marijuana growers. Others provide supplies to marijuana growers. Then there's the third type of marijuana stock: the biotechs. Zynerba Pharmaceuticals belongs to the last kind of marijuana stock. Like other...